Klaus Gustav Strein
Direttore/Membro del Consiglio presso NOVIMMUNE SA
Profilo
Klaus Gustav Strein is the founder and currently holds the position of Chairman at EngMab SARL, which was founded in 2013.
He is also currently a Member-Supervisory Board at NovImmune SA and Berta Holding AG.
In the past, he served as Chairman-Supervisory Board at Lamkap Bio Gamma AG, Lamkap Bio Alpha AG, and LamKap Bio beta AG.
He was also a Member-Supervisory Board at BB Biotech AG.
From 1998 to 2011, he worked at Roche Holding AG as the Head-Small Molecules Research.
Dr. Strein obtained a doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Posizioni attive di Klaus Gustav Strein
| Società | Posizione | Inizio |
|---|---|---|
| NOVIMMUNE SA | Direttore/Membro del Consiglio | - |
EngMab SARL
 EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Fondatore | 01/01/2013 |
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Klaus Gustav Strein
| Società | Posizione | Fine |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 14/09/2011 |
| Lamkap Bio Gamma AG | Presidente | - |
| Lamkap Bio Alpha AG | Presidente | - |
LamKap Bio beta AG
 LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Presidente | - |
| BB BIOTECH AG | Direttore/Membro del Consiglio | - |
Formazione di Klaus Gustav Strein
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| BB BIOTECH AG | Finance |
| Aziende private | 6 |
|---|---|
EngMab SARL
EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
LamKap Bio beta AG
LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
| Lamkap Bio Alpha AG | |
| Lamkap Bio Gamma AG | |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Klaus Gustav Strein
